| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Announcements
|
|
|
1995
|
10 |
1 |
p. 63-64
|
article
|
| 2 |
Clinical significance of inverted PSA/PAP ratio in prostate cancer patients
|
Morote, J.
|
|
1995
|
10 |
1 |
p. 58
|
article
|
| 3 |
Cyfra 21-1 in Bronchoalveolar Lavage: Preliminary Results
|
Blasco, R.F.
|
|
1995
|
10 |
1 |
p. 55-57
|
article
|
| 4 |
DNA content in human colon cancer and non-neoplastic adjacent mucosa
|
Jotti, G. Saccani
|
|
1995
|
10 |
1 |
p. 11-16
|
article
|
| 5 |
Effects of granulocyte colony stimulating factor on the specific macrophage marker neopterin in cancer patients
|
Lissoni, P.
|
|
1995
|
10 |
1 |
p. 61-62
|
article
|
| 6 |
Eosinophilia induced by interleukin-2 cancer immunotherapy may be associated with enhanced production of total IgE
|
Vecchi, L.
|
|
1995
|
10 |
1 |
p. 59-60
|
article
|
| 7 |
Immunocytochemical determination of the tumor-associated glycoproteins MCA, CA 125 and BW 495/36-P in urine of patients with epithelial tumors of the kidney and urinary bladder
|
Ammon, A.
|
|
1995
|
10 |
1 |
p. 17-23
|
article
|
| 8 |
Longitudinal follow-up of breast cancer patients with the tumor markers CA 549 and CA 15.3
|
Vankrieken, L.
|
|
1995
|
10 |
1 |
p. 30-34
|
article
|
| 9 |
Neuron-specific enolase (NSE) in serum. Comparison of monoclonal versus polyclonal assay based on 392 blood samples
|
Drivsholm, L.
|
|
1995
|
10 |
1 |
p. 1-4
|
article
|
| 10 |
Progesterone agonists and antagonists induce down– and up–regulation of estrogen receptors and estrogen inducible genes in human breast cancer cell lines
|
Savoldi, G.
|
|
1995
|
10 |
1 |
p. 47-54
|
article
|
| 11 |
Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer
|
Diez, M.
|
|
1995
|
10 |
1 |
p. 5-10
|
article
|
| 12 |
Skeletal alkaline phosphatase as a serum marker of bone metastases in the follow-up of patients with breast cancer
|
Reale, M.G.
|
|
1995
|
10 |
1 |
p. 42-46
|
article
|
| 13 |
Study of serum tumor markers CEA, CA 15.3 and CA 27.29 as diagnostic parameters in patients with breast carcinoma
|
De Paterna, L. Rodríguez
|
|
1995
|
10 |
1 |
p. 24-29
|
article
|
| 14 |
The clinical value of CEA and CA 15-3 in breast cancer management
|
Coveney, E.C.
|
|
1995
|
10 |
1 |
p. 35-41
|
article
|
Journal description